Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 18 de 18
Filter
Add more filters











Publication year range
1.
BJA Educ ; 19(8): 261-266, 2019 Aug.
Article in English | MEDLINE | ID: mdl-33456900
2.
Toxicology ; 238(1): 49-59, 2007 Aug 16.
Article in English | MEDLINE | ID: mdl-17624652

ABSTRACT

This is a comparative study of the mechanisms by which three different rodent non-genotoxic carcinogens modulate connexin-mediated gap junction intercellular communication in male rat liver in vivo. In the case of the peroxisome proliferating agent Wy-14,643, a non-hepatotoxic dose of 50mg/kg led to a marked loss of inter-hepatocyte dye transfer associated with a loss of both Cx32 and Cx26 protein expression. In contrast, p,p'-dichlorodiphenyltrichloroethane (DDT) at a non-hepatotoxic dose (25mg/kg) was not found to alter Cx32 or Cx26 expression or to produce a measurable Cx32 serine phosphorylation but did give a small, significant reduction of cell communication. Carbon tetrachloride (CCl(4)) did not affect cell communication (despite a small significant reduction of Cx32 content) at a non-hepatotoxic dose. Both loss of communication and Cx32 expression was observed only at a dose that caused hepatocyte toxicity as evidenced by increased serum alanine aminotransferase activity. Overall, the findings emphasise that loss of gap junctional communication in vivo can contribute to carcinogenesis by non-genotoxic carcinogens through different primary mechanism. In contrast to Wy-14,643 and DDT, the results with CCl(4) are consistent with a requirement for hepatotoxicity in its carcinogenic action.


Subject(s)
Carcinogens/toxicity , Cell Communication/drug effects , Gap Junctions/drug effects , Liver/drug effects , Administration, Oral , Alanine Transaminase/metabolism , Animals , Carbon Tetrachloride/administration & dosage , Carbon Tetrachloride/chemistry , Carbon Tetrachloride/toxicity , Carcinogens/chemistry , Cell Proliferation/drug effects , Connexin 26 , Connexins/metabolism , DDT/administration & dosage , DDT/chemistry , DDT/toxicity , Dose-Response Relationship, Drug , Gap Junctions/physiology , Hepatocytes/drug effects , Hepatocytes/metabolism , Hepatocytes/pathology , Immunoblotting , Injections, Intraperitoneal , Liver/metabolism , Liver/pathology , Male , Palmitoyl Coenzyme A/metabolism , Peroxisomes/drug effects , Peroxisomes/metabolism , Phosphorylation/drug effects , Pyrimidines/administration & dosage , Pyrimidines/chemistry , Pyrimidines/toxicity , Rats , Rats, Wistar , Gap Junction beta-1 Protein
3.
Mol Biol Cell ; 12(1): 37-51, 2001 Jan.
Article in English | MEDLINE | ID: mdl-11160821

ABSTRACT

Transport of proteins through the ALP (alkaline phosphatase) pathway to the vacuole requires the function of the AP-3 adaptor complex and Vps41p. However, unlike other adaptor protein-dependent pathways, the ALP pathway has not been shown to require additional accessory proteins or coat proteins, such as membrane recruitment factors or clathrin. Two independent genetic approaches have been used to identify new mutants that affect transport through the ALP pathway. These screens yielded new mutants in both VPS41 and the four AP-3 subunit genes. Two new VPS41 alleles exhibited phenotypes distinct from null mutants of VPS41, which are defective in vacuolar morphology and protein transport through both the ALP and CPY sorting pathways. The new alleles displayed severe ALP sorting defects, normal vacuolar morphology, and defects in ALP vesicle formation at the Golgi complex. Sequencing analysis of these VPS41 alleles revealed mutations encoding amino acid changes in two distinct domains of Vps41p: a conserved N-terminal domain and a C-terminal clathrin heavy-chain repeat (CHCR) domain. We demonstrate that the N-terminus of Vps41p is required for binding to AP-3, whereas the C-terminal CHCR domain directs homo-oligomerization of Vps41p. These data indicate that a homo-oligomeric form of Vps41p is required for the formation of ALP containing vesicles at the Golgi complex via interactions with AP-3.


Subject(s)
Alkaline Phosphatase/metabolism , Carrier Proteins/metabolism , Carrier Proteins/pharmacology , Membrane Proteins/metabolism , Monomeric Clathrin Assembly Proteins , Nuclear Proteins , RNA-Binding Proteins/pharmacology , Saccharomyces cerevisiae Proteins , Vesicular Transport Proteins , Adaptor Proteins, Vesicular Transport , Alleles , Amino Acid Sequence , Binding Sites , Carrier Proteins/genetics , Clathrin/genetics , Clathrin/pharmacology , Clathrin Heavy Chains , Dimerization , Fungal Proteins/genetics , Fungal Proteins/metabolism , Fungal Proteins/pharmacology , Membrane Proteins/genetics , Membrane Proteins/pharmacology , Molecular Sequence Data , Mutation , Phenotype , Protein Binding , Protein Structure, Tertiary , Protein Transport/drug effects , Protein Transport/genetics , RNA-Binding Proteins/genetics , RNA-Binding Proteins/metabolism , Saccharomyces cerevisiae/chemistry , Sequence Alignment , Transport Vesicles/drug effects
4.
J Bacteriol ; 182(22): 6339-46, 2000 Nov.
Article in English | MEDLINE | ID: mdl-11053377

ABSTRACT

Pseudomonas putida converts benzoate to catechol using two enzymes that are encoded on the chromosome and whose expression is induced by benzoate. Benzoate also binds to the regulator XylS to induce expression of the TOL (toluene degradation) plasmid-encoded meta pathway operon for benzoate and methylbenzoate degradation. Finally, benzoate represses the ability of P. putida to transport 4-hydroxybenzoate (4-HBA) by preventing transcription of pcaK, the gene encoding the 4-HBA permease. Here we identified a gene, benR, as a regulator of benzoate, methylbenzoate, and 4-HBA degradation genes. A benR mutant isolated by random transposon mutagenesis was unable to grow on benzoate. The deduced amino acid sequence of BenR showed high similarity (62% identity) to the sequence of XylS, a member of the AraC family of regulators. An additional seven genes located adjacent to benR were inferred to be involved in benzoate degradation based on their deduced amino acid sequences. The benABC genes likely encode benzoate dioxygenase, and benD likely encodes 2-hydro-1,2-dihydroxybenzoate dehydrogenase. benK and benF were assigned functions as a benzoate permease and porin, respectively. The possible function of a final gene, benE, is not known. benR activated expression of a benA-lacZ reporter fusion in response to benzoate. It also activated expression of a meta cleavage operon promoter-lacZ fusion inserted in an E. coli chromosome. Third, benR was required for benzoate-mediated repression of pcaK-lacZ fusion expression. The benA promoter region contains a direct repeat sequence that matches the XylS binding site previously defined for the meta cleavage operon promoter. It is likely that BenR binds to the promoter region of chromosomal benzoate degradation genes and plasmid-encoded methylbenzoate degradation genes to activate gene expression in response to benzoate. The action of BenR in repressing 4-HBA uptake is probably indirect.


Subject(s)
Bacterial Proteins/genetics , Benzoates/metabolism , Genes, Bacterial , Genes, Regulator , Pseudomonas putida/genetics , Repressor Proteins/genetics , Trans-Activators/genetics , Amino Acid Sequence , Bacterial Proteins/metabolism , DNA-Binding Proteins , Molecular Sequence Data , Parabens/metabolism , Pseudomonas putida/metabolism , Repressor Proteins/metabolism , Sequence Alignment , Sequence Homology, Amino Acid , Trans-Activators/metabolism , Transcription, Genetic
5.
Nature ; 407(6803): 513-6, 2000 Sep 28.
Article in English | MEDLINE | ID: mdl-11029002

ABSTRACT

Most genomic variation is attributable to single nucleotide polymorphisms (SNPs), which therefore offer the highest resolution for tracking disease genes and population history. It has been proposed that a dense map of 30,000-500,000 SNPs can be used to scan the human genome for haplotypes associated with common diseases. Here we describe a simple but powerful method, called reduced representation shotgun (RRS) sequencing, for creating SNP maps. RRS re-samples specific subsets of the genome from several individuals, and compares the resulting sequences using a highly accurate SNP detection algorithm. The method can be extended by alignment to available genome sequence, increasing the yield of SNPs and providing map positions. These methods are being used by The SNP Consortium, an international collaboration of academic centres, pharmaceutical companies and a private foundation, to discover and release at least 300,000 human SNPs. We have discovered 47,172 human SNPs by RRS, and in total the Consortium has identified 148,459 SNPs. More broadly, RRS facilitates the rapid, inexpensive construction of SNP maps in biomedically and agriculturally important species. SNPs discovered by RRS also offer unique advantages for large-scale genotyping.


Subject(s)
Chromosome Mapping/methods , Genome, Human , Polymorphism, Single Nucleotide , Algorithms , Gene Library , Humans , Molecular Sequence Data , Sequence Alignment , Sequence Analysis, DNA
6.
Trends Cell Biol ; 8(7): 282-8, 1998 Jul.
Article in English | MEDLINE | ID: mdl-9714600

ABSTRACT

A new adaptor protein complex, termed AP-3, has recently been identified in mammalian cells, and genetic studies in yeast have revealed a functional role for the AP-3 complex in cargo-selective transport via a new alternative trafficking pathway from the Golgi to the vacuole/lysosome. Here, the authors review what is currently known about the AP-3 complex and discuss recent insight into its function in multicellular organisms that has come from the finding that mutations in AP-3 subunits correspond to classical mutations in Drosophila and mice.


Subject(s)
Enzyme Inhibitors/metabolism , Golgi Apparatus/metabolism , Lysosomes/metabolism , Monomeric Clathrin Assembly Proteins , Nerve Tissue Proteins/physiology , Phosphoproteins/physiology , Adaptor Proteins, Vesicular Transport , Animals , Biological Transport/physiology , Eukaryotic Cells/chemistry , Eukaryotic Cells/metabolism , Golgi Apparatus/chemistry , Lysosomes/chemistry
7.
Cell ; 91(1): 109-18, 1997 Oct 03.
Article in English | MEDLINE | ID: mdl-9335339

ABSTRACT

Three distinct adaptor protein (AP) complexes involved in protein trafficking have been identified. AP-1 and AP-2 mediate protein sorting at the trans-Golgi network and plasma membrane, respectively, whereas the function of AP-3 has not been defined. A screen for factors specifically involved in transport of alkaline phosphatase (ALP) from the Golgi to the vacuole/lysosome has identified Ap16p and Ap15p of the yeast AP-3 complex. Deletion of each of the four AP-3 subunits results in selective mislocalization of ALP and the vacuolar t-SNARE, Vam3p (but not CPS and CPY), while deletion of AP-1 and AP-2 subunits has no effect on vacuolar protein delivery. This study, therefore, provides evidence that the AP-3 complex functions in cargo-selective protein transport from the Golgi to the vacuole/lysosome.


Subject(s)
Alkaline Phosphatase/metabolism , Fungal Proteins/physiology , Monomeric Clathrin Assembly Proteins , Saccharomyces cerevisiae Proteins , Saccharomyces cerevisiae/metabolism , Vacuoles/enzymology , Adaptor Protein Complex alpha Subunits , Adaptor Proteins, Vesicular Transport , Alkaline Phosphatase/genetics , Biological Transport , Carboxypeptidases/metabolism , Cathepsin A , Dipeptidyl-Peptidases and Tripeptidyl-Peptidases/genetics , Dipeptidyl-Peptidases and Tripeptidyl-Peptidases/metabolism , Fungal Proteins/genetics , Fungal Proteins/metabolism , Golgi Apparatus/enzymology , Lysosomes/enzymology , Membrane Proteins/metabolism , Membrane Proteins/physiology , Qa-SNARE Proteins , Recombinant Fusion Proteins , Saccharomyces cerevisiae/enzymology , Saccharomyces cerevisiae/genetics , Sequence Deletion
8.
Mol Biol Cell ; 8(6): 1089-104, 1997 Jun.
Article in English | MEDLINE | ID: mdl-9201718

ABSTRACT

The vacuolar protein-sorting (VPS) pathway of Saccharomyces cerevisiae mediates localization of proteins from the trans-Golgi to the vacuole via a prevacuolar endosome compartment. Mutations in class D vacuolar protein-sorting (vps) genes affect vesicle-mediated Golgi-to-endosome transport and result in secretion of vacuolar proteins. Temperature-sensitive-for-function (tsf) and dominant negative mutations in PEP12, encoding a putative SNARE vesicle receptor on the endosome, and tsf mutations in VAC1, a gene implicated in vacuole inheritance and vacuolar protein sorting, were constructed and used to demonstrate that Pep12p and Vac1p are components of the VPS pathway. The sequence of Vac1p contains two putative zinc-binding RING motifs, a zinc finger motif, and a coiled-coil motif. Site-directed mutations in the carboxyl-terminal RING motif strongly affected vacuolar protein sorting. Vac1p was found to be tightly associated with membranes as a monomer and in a large SDS-resistant complex. By using Pep12p affinity chromatography, we found that Vac1p, Vps45p (SEC1 family member), and Sec18p (yeast N-ethyl maleimide-sensitive factor, NSF) bind Pep12p. Consistent with a functional role for this complex in vacuolar protein sorting, double pep12tsfvac1tsf and pep12tsf vps45tsf mutants exhibited synthetic Vps- phenotypes, the tsf phenotype of the vac1tsf mutant was rescued by overexpression of VPS45 or PEP12, overexpression of a dominant pep12 allele in a sec18-1 strain resulted in a severe synthetic growth defect that was rescued by deletion of PEP12 or VAC1, and subcellular fractionation of vac1 delta cells revealed a striking change in the fractionation of Pep12p and Vps21p, a rab family GTPase required for vacuolar protein sorting. The functions of Pep12p, Vps45p, and Vps21p indicate that key aspects of Golgi-to-endosome trafficking are similar to other vesicle-mediated transport steps, although the role of Vac1p suggests that there are also novel components of the VPS pathway.


Subject(s)
Adenosine Triphosphatases , Cytoskeletal Proteins , Endosomes/metabolism , Fungal Proteins/genetics , Golgi Apparatus/metabolism , Membrane Proteins/metabolism , Saccharomyces cerevisiae Proteins , Saccharomyces cerevisiae/metabolism , Vacuoles/metabolism , Vesicular Transport Proteins , rab GTP-Binding Proteins , Adaptor Proteins, Signal Transducing , Biological Transport , Cell Compartmentation , Fungal Proteins/metabolism , Fungal Proteins/physiology , GTP-Binding Proteins/metabolism , Macromolecular Substances , Membrane Fusion , Protein Binding , Qa-SNARE Proteins , Saccharomyces cerevisiae/genetics , Structure-Activity Relationship , Zinc/metabolism
9.
EMBO J ; 16(10): 2769-82, 1997 May 15.
Article in English | MEDLINE | ID: mdl-9184222

ABSTRACT

More than 40 vacuolar protein sorting (vps) mutants have been identified which secrete proenzyme forms of soluble vacuolar hydrolases to the cell surface. A subset of these mutants has been found to show selective defects in the sorting of two vacuolar membrane proteins. Under non-permissive conditions, vps45tsf (SEC1 homolog) and pep12/vps6tsf (endosomal t-SNARE) mutants efficiently sort alkaline phosphatase (ALP) to the vacuole while multiple soluble vacuolar proteins and the membrane protein carboxypeptidase yscS (CPS) are no longer delivered to the vacuole. Vacuolar localization of ALP in these mutants does not require transport to the plasma membrane followed by endocytic uptake, as double mutants of pep12tsf and vps45tsf with sec1 and end3 sort and mature ALP at the non-permissive temperature. Given the demonstrated role of t-SNAREs such as Pep12p in transport vesicle recognition, our results indicate that ALP and CPS are packaged into distinct transport intermediates. Consistent with ALP following an alternative route to the vacuole, isolation of a vps41tsf mutant revealed that at non-permissive temperature ALP is mislocalized while vacuolar delivery of CPS and CPY is maintained. A series of domain-swapping experiments was used to define the sorting signal that directs selective packaging and transport of ALP. Our data demonstrate that the amino-terminal 16 amino acid portion of the ALP cytoplasmic tail domain contains a vacuolar sorting signal which is responsible for the active recognition, packaging and transport of ALP from the Golgi to the vacuole via a novel delivery pathway.


Subject(s)
Carrier Proteins/metabolism , Cell Compartmentation , Golgi Apparatus/physiology , Nuclear Proteins , RNA-Binding Proteins/metabolism , Saccharomyces cerevisiae Proteins , Saccharomyces cerevisiae/physiology , Vacuoles/physiology , Vesicular Transport Proteins , Alkaline Phosphatase/genetics , Alkaline Phosphatase/metabolism , Amino Acid Sequence , Biological Transport , Carboxypeptidases/genetics , Carboxypeptidases/metabolism , Carrier Proteins/genetics , Cathepsin A , Fungal Proteins/genetics , Fungal Proteins/metabolism , Membrane Proteins/genetics , Membrane Proteins/metabolism , Models, Biological , Molecular Sequence Data , Qa-SNARE Proteins , RNA-Binding Proteins/genetics , Recombinant Fusion Proteins/metabolism , Saccharomyces cerevisiae/ultrastructure
10.
J Biol Chem ; 271(52): 33607-15, 1996 Dec 27.
Article in English | MEDLINE | ID: mdl-8969229

ABSTRACT

Genetic analyses of vacuolar protein sorting in Saccharomyces cerevisiae have uncovered a large number of mutants (vps) that missort and secrete soluble vacuolar hydrolases. Here we report the characterization of the gene product affected in one of these mutants, Vps8p. Polyclonal antiserum raised against a trpE-Vps8 fusion protein specifically detects a 134-kDa protein in labeled yeast cell extracts. Subcellular fractionation studies demonstrate that Vps8p is distributed between a low speed membrane pellet fraction and a high speed membrane pellet fraction. The lack of a hydrophobic domain in Vps8p suggests that Vps8p peripherally associates with a membrane(s). This association was found to depend on the function of Vps21p, a member of the Rab/Ypt/Sec4 family of small GTPases. In vps21 null mutant cells, Vps8p is found in the cytosol. In addition, overexpression of Vps21p partially suppresses a vps8 null mutant, indicating that Vps8p and Vps21p functionally interact. Vps8p contains a C-terminal cysteine-rich region that conforms to the H2 variant of the RING finger Zn2+ binding motif. Truncation of this C-terminal region partially compromises Vps8p function. While vps8 null mutant strains missort and secrete soluble vacuolar hydrolases, the integral vacuolar membrane protein, alkaline phosphatase (ALP), is sorted to the vacuole and matured normally. In addition, when vps8 mutants are combined with endocytic or late secretory pathway mutants (end3 or sec1, respectively), ALP is still delivered to the vacuole. These observations indicate that ALP is sorted to the vacuole in a Vps8p-independent manner, possibly via an alternative vesicle carrier.


Subject(s)
Carrier Proteins/metabolism , Fungal Proteins/metabolism , GTP Phosphohydrolases/metabolism , GTP-Binding Proteins/metabolism , Saccharomyces cerevisiae Proteins , Vesicular Transport Proteins , rab GTP-Binding Proteins , Alkaline Phosphatase/metabolism , Amino Acid Sequence , Carrier Proteins/chemistry , Electrophoresis, Polyacrylamide Gel , Molecular Sequence Data , Restriction Mapping , Saccharomyces cerevisiae , Subcellular Fractions/chemistry
11.
J Cell Sci ; 107 ( Pt 12): 3449-59, 1994 Dec.
Article in English | MEDLINE | ID: mdl-7706396

ABSTRACT

Genetic analyses of vacuolar protein sorting in Saccharomyces cerevisiae have uncovered a large number of mutants (vps) that missort and secrete vacuolar hydrolases. A small subset of vps mutants exhibit a temperature-conditional growth phenotype and show a severe defect in the localization of soluble vacuolar proteins, yet maintain a near-normal vacuole structure. Here, we report on the cloning and characterization of the gene affected in one of these mutants, VPS45, which has been found to encode a member of a protein family that includes the yeast proteins Sec1p, Sly1p and Vps33p, as well as n-Sec1, UNC18 and Rop from other eukaryotic organisms. These proteins are thought to participate in vesicle-mediated protein transport events. Polyclonal antiserum raised against a TrpE-Vps45 fusion protein specifically detects a stable 67 kDa protein in labeled yeast cell extracts. Subcellular fractionation studies demonstrate that the majority of Vps45p is associated with a high-speed membrane pellet fraction that includes Golgi, transport vesicles and, potentially, endosomal membranes. Significantly, this fraction lacks ER, vacuole and plasma membranes. Overexpression of Vps45p saturates the sites with which Vps45p associates. A vps45 null mutant accumulates vesicles, many of which were found to be present in large clusters. This accumulation of potential transport vesicles indicates that Vps45p may facilitate the targeting and/or fusion of these vesicles in the vacuolar protein sorting pathway.


Subject(s)
Cell Compartmentation/physiology , Fungal Proteins/genetics , Intracellular Membranes/metabolism , Nerve Tissue Proteins , Saccharomyces cerevisiae Proteins , Saccharomyces cerevisiae/metabolism , Vacuoles/metabolism , Vesicular Transport Proteins , Amino Acid Sequence , Base Sequence , Biological Transport , Biomarkers , Cell Fractionation , Cloning, Molecular , Fungal Proteins/isolation & purification , Genes, Fungal/genetics , Intracellular Membranes/ultrastructure , Molecular Sequence Data , Munc18 Proteins , Mutagenesis , Recombinant Proteins/isolation & purification , Saccharomyces cerevisiae/genetics , Saccharomyces cerevisiae/ultrastructure , Sequence Analysis, DNA , Sequence Homology, Amino Acid , Vacuoles/ultrastructure
12.
Health Care Financ Rev ; 12(3): 21-5, 1991.
Article in English | MEDLINE | ID: mdl-10110876

ABSTRACT

Hospitals seeking Medicare payment are required to submit Medicare Cost Reports to their respective fiscal intermediaries, who in turn are required to desk review and sometimes audit the reports. The reviewed or audited report is considered more reliable than the originally submitted report and provides the basis for final Medicare payment. This study quantifies the impact of the review process, finding that, for the most part, the effect is quite small, usually less than 1 percent. Passthrough costs, however, were the exception to this rule. Capital and education passthrough costs, on a per discharge basis, were reduced about 6 percent.


Subject(s)
Financial Audit , Financial Management, Hospital , Medicare Part A/organization & administration , Prospective Payment System/statistics & numerical data , Capital Expenditures , Centers for Medicare and Medicaid Services, U.S. , Costs and Cost Analysis/statistics & numerical data , Education, Medical/economics , Evaluation Studies as Topic , Models, Statistical , Regression Analysis , United States
14.
J Pediatr ; 86(1): 43-9, 1975 Jan.
Article in English | MEDLINE | ID: mdl-162954

ABSTRACT

A 3-yr-old boy was investigated for numerous episodes of fatigue, irritability, pallor, and sweating, which began at 11 mo of age, when he had an episode of symptomatic hypoglycemia with ketonuria. He had euphoria, mental confusion, drowsiness, nausea, and vomiting 1-5 hr after oral administration of glycerol in doses of 0.5-1.0gm/kg. Orally administered MCT (1 gm/kg) had similar effects. On one occasion, oral glycerol also provoked hypoglycemia, as had a 16 1/2 hr fast. Intravenously administered glycerol (0.09 gm/kg) induced an immediate loss of consciousness from which he recovered spontaneously after 30 min; there were no changes in blood glucose values. Intravenously administered fructose (0.25 gm/kg) was tolerated normally. Leukocytes showed normal activities for FDPase, glycerol kinase, and glycerol phosphate dehydrogenase. The restriction of dietary intake of fat has been associated with a marked improvement in physical and mental activities. These observations suggest a unique, yet undifined intolerance to glycerol, which suggest caution in the diagnostic use of glycerol in the investigation of hypoglycemia as well as in the therapy of increased intracranial or intraocular pressure.


Subject(s)
Glycerol/adverse effects , Hypoglycemia/metabolism , Alanine/blood , Carbon Radioisotopes , Child, Preschool , Consciousness/drug effects , Fructose/metabolism , Fructose-Bisphosphatase/blood , Glucagon/metabolism , Glycerol/metabolism , Glycerolphosphate Dehydrogenase/blood , Growth Hormone/blood , Humans , Hydrocortisone/blood , Hydroxybutyrates/blood , Hypoglycemia/blood , Insulin/blood , Leukocytes/enzymology , Leukocytes/metabolism , Male , Seizures/chemically induced , Sweating/drug effects , Triglycerides/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL